Search results
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 17 hours agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoA total of 604 patients across 39 sites in China participated in the study. The primary goal of the...
Understanding the Link Between Psoriasis and Social Anxiety
Verywell Health via Yahoo News· 2 days agoPsoriasis can lead to mental health concerns like social anxiety, and anxiety can trigger psoriasis...
Psoriasis Skin Care Guide | Healthline
Healthline· 6 days agoYour skin care routine matters when it comes to relieving painful, itchy patches of inflamed skin in psoriasis. Knowing how to care for psoriasis skin —...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 11 hours agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
6 Psoriasis Home Remedies to Try
Healthline· 6 days agoThis means no home remedy can completely relieve your symptoms with a guarantee they won’t return someday. Psoriasis can be very unique to each...
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
GuruFocus.com via Yahoo Finance· 21 hours agoThis positions JNJ-2113, a novel oral IL-23 receptor antagonist, as a potential leader in psoriasis ...
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 1 day agoThe company expects to report top-line results from the SAD/MAD...optimal oral bioavailability. VYNE...
ILD Not Increased With MTX in Patients With Dermatomyositis
Medscape· 7 days agoTreatment with methotrexate was not associated with an increased risk for interstitial lung disease...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 1 day agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...